GEO Investing

According to the Company’s 8-K filed on June 23, 2015, Great Basin Scientific amended and restated the terms governing the Series C Warrants and Series E Convertible Preferred Stock issued by the Company. We believe that holders of these warrants […]

According to a report in the Chinese media, Qihoo 360 Technology (NYSE:QIHU) is entering into the medical e-commerce sector by forming a joint company with a subsidiary of China National Pharmaceutical Group Corporation (Sinopharm). As noted in the linked article, Sinopharm […]

Documents filed by Great Basin Scientific (GBSN) offer insight on potential stock dilution that is on the way.  On April 20 and 22, 2015 the company filed a series of 424(B)(3) prospectuses detailing the circumstances that would allow 32 million shares […]

Yesterday, the company filed an 8-K indicating that a $500k convertible promissory note term issued to the company, at 20% per annum, from its Chairman of the Board had been extended for an additional year. The cost to extend the […]

BioSig Technoliges (BSGM) this morning announced that it has retained Donohoe Advisory Associates LLC of Rockville, Maryland to advise and assist the Company in its efforts to obtain an uplisting on a national securities exchange. BioSig Technologies is a medical device company that has […]

GeoInvesting is currently short Great Basic Scientific (GBSN), a rapid diagnostic medical test (Nucleic Acid Assay Testing) firm. We first alerted GeoInvesting premium members that we identified red flags associated with GBSN on March 30, 2015. In our March 30 e-mail to […]

On March 30, 2014 GeoInvesting stated that it was taking a closer look at Great Basin Scientific (GBSN) as just 3 months after the company went public on October 9, 2014, we received a promotional pump, e-mail newsletter. The day of […]